This is a Validated Antibody Database (VAD) review about human CD73, based on 147 published articles (read how Labome selects the articles), using CD73 antibody in all methods. It is aimed to help Labome visitors find the most suited CD73 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD73 synonym: CALJA; CD73; E5NT; NT; NT5; NTE; eN; eNT

others
  • flow cytometry; human; loading ...; fig 5
 CD73 antibody (R&D Systems, clone 606112) was used in flow cytometry on human samples (fig 5). Sci Rep (2019) ncbi
Santa Cruz Biotechnology
  • immunohistochemistry - paraffin section; mouse; 2 ug/ml; loading ...; fig 7k
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in immunohistochemistry - paraffin section on mouse samples at 2 ug/ml (fig 7k). Cell Mol Gastroenterol Hepatol (2021) ncbi
  • immunohistochemistry; mouse; 1:300; loading ...; fig 4e
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in immunohistochemistry on mouse samples at 1:300 (fig 4e). Nature (2019) ncbi
  • western blot; mouse; loading ...; fig 2c
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on mouse samples (fig 2c). Nat Microbiol (2019) ncbi
  • western blot; human; loading ...; fig 2a
Santa Cruz Biotechnology CD73 antibody (SantaCruz, H-300) was used in western blot on human samples (fig 2a). Mol Psychiatry (2018) ncbi
  • immunocytochemistry; human; 1:2000; loading ...; fig 1e
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in immunocytochemistry on human samples at 1:2000 (fig 1e). Oncogene (2018) ncbi
  • western blot; mouse; 1:1000; loading ...; fig s2c
Santa Cruz Biotechnology CD73 antibody (Santa, H-300) was used in western blot on mouse samples at 1:1000 (fig s2c). Nat Commun (2018) ncbi
  • western blot; mouse; fig 3a
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H300) was used in western blot on mouse samples (fig 3a). J Steroid Biochem Mol Biol (2018) ncbi
  • immunocytochemistry; mouse; loading ...; fig 8a
Santa Cruz Biotechnology CD73 antibody (SantaCruz, H300) was used in immunocytochemistry on mouse samples (fig 8a). J Neurosci (2017) ncbi
  • western blot; mouse; fig s10
Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, H-300) was used in western blot on mouse samples (fig s10). Cell Death Dis (2017) ncbi
  • western blot; human; 1:1000; loading ...; fig 4b
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on human samples at 1:1000 (fig 4b). FASEB J (2017) ncbi
  • western blot; human; loading ...; fig 6a
In order to find that a subset of SLC25A46 interacts with mitochondrial dynamics components and the MICOS complex, Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on human samples (fig 6a). Mol Biol Cell (2017) ncbi
  • western blot; human; loading ...; fig 5b
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on human samples (fig 5b). Cell Death Dis (2016) ncbi
  • immunocytochemistry; human; loading ...; fig s3b
  • western blot; human; loading ...; fig s2f
Santa Cruz Biotechnology CD73 antibody (SantaCruz, H-300) was used in immunocytochemistry on human samples (fig s3b) and in western blot on human samples (fig s2f). J Cell Biol (2016) ncbi
  • western blot; mouse; 1:500; loading ...; fig 5b
In order to study cancer-testis antigen expression in a mouse model of prostate cancer, Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on mouse samples at 1:500 (fig 5b). Prostate (2017) ncbi
  • immunohistochemistry; human; 1:100; fig 2e, 2f
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in immunohistochemistry on human samples at 1:100 (fig 2e, 2f). Diagn Pathol (2016) ncbi
  • western blot; mouse; loading ...; fig 1b
Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, H-300) was used in western blot on mouse samples (fig 1b). Sci Rep (2016) ncbi
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2a
  • immunocytochemistry; mouse; fig 4b
  • western blot; mouse; loading ...; fig 2b
Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, H-300) was used in immunohistochemistry - frozen section on mouse samples (fig 2a), in immunocytochemistry on mouse samples (fig 4b) and in western blot on mouse samples (fig 2b). PLoS Pathog (2016) ncbi
  • western blot; human; loading ...; fig 3d
Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, H-300) was used in western blot on human samples (fig 3d). Oncol Rep (2016) ncbi
  • immunohistochemistry; mouse; 1:400; loading ...; fig st1
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in immunohistochemistry on mouse samples at 1:400 (fig st1). Gastroenterology (2016) ncbi
mouse monoclonal (IE9)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, sc-32299) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Oncol Lett (2016) ncbi
  • western blot; rat; 1:1000; loading ...; fig 7c
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on rat samples at 1:1000 (fig 7c). PLoS ONE (2016) ncbi
mouse monoclonal (IE9)
  • western blot; domestic rabbit; 1:1000; fig 7
In order to examine the role of meniscus-derived stromal cells in healing, Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, sc-32299) was used in western blot on domestic rabbit samples at 1:1000 (fig 7). Cytotechnology (2016) ncbi
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Santa Cruz Biotechnology CD73 antibody (SCBT, H-300) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
  • flow cytometry; mouse; fig s1
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in flow cytometry on mouse samples (fig s1). Sci Rep (2015) ncbi
  • western blot; human; 1:1000; loading ...; fig 1c
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, H-300) was used in western blot on human samples at 1:1000 (fig 1c). DNA Repair (Amst) (2015) ncbi
  • western blot; mouse; loading ...; fig s3a
Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, H-300) was used in western blot on mouse samples (fig s3a). Cell Death Differ (2015) ncbi
  • immunocytochemistry; human; 1:100; tbl 1
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, sc25603) was used in immunocytochemistry on human samples at 1:100 (tbl 1). Acta Biomater (2015) ncbi
mouse monoclonal (IE9)
  • western blot; human; fig 4
Santa Cruz Biotechnology CD73 antibody (Santa Cruz, sc-32299) was used in western blot on human samples (fig 4). Oncol Rep (2015) ncbi
  • western blot; rhesus macaque; loading ...; fig 8a
Santa Cruz Biotechnology CD73 antibody (Santa Cruz Biotechnology, H-300) was used in western blot on rhesus macaque samples (fig 8a). Mol Ther (2014) ncbi
BioLegend
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1a
BioLegend CD73 antibody (BioLegend, 344004) was used in flow cytometry on human samples (fig 1a). World J Stem Cells (2022) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD73 antibody (Biolegend, 344004) was used in flow cytometry on human samples (fig s1b). Stem Cell Res Ther (2022) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BioLegend CD73 antibody (Biolegend, 344008) was used in flow cytometry on human samples . Front Immunol (2022) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD73 antibody (Biologend, 344003) was used in flow cytometry on human samples (fig 1b). Sci Rep (2021) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD73 antibody (BioLegend, 344016) was used in flow cytometry on human samples (fig 1). Bone Joint Res (2021) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 2-5
BioLegend CD73 antibody (BioLegend, AD2) was used in flow cytometry on human samples (fig 2-5). Cells (2020) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:25; loading ...; fig s2
BioLegend CD73 antibody (Biolegend, 344015) was used in flow cytometry on human samples at 1:25 (fig s2). Stem Cell Res Ther (2020) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 2k
BioLegend CD73 antibody (BioLegend, AD2) was used in flow cytometry on human samples (fig 2k). Cell Death Dis (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
BioLegend CD73 antibody (BioLegend, 344016) was used in flow cytometry on human samples (fig 1). Int J Mol Med (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 4b
In order to define a differentiation system to generate definitive hematopoietic multipotent progenitor cells from hemato-endothelial progenitors via the endothelial monolayer, BioLegend CD73 antibody (BioLegend, AD2) was used in flow cytometry on human samples (fig 4b). J Cell Physiol (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 3
BioLegend CD73 antibody (BioLegend, AD2) was used in flow cytometry on human samples (fig 3). J Autoimmun (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BioLegend CD73 antibody (Biolegend, AD2) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (AD2)
In order to investigate the roles of SCRG1 and BST1 to the self-renewal, migration, and osteogenic differentiation of human mesenchymal stem cells, BioLegend CD73 antibody (Biolegend, 344015) was used . Sci Rep (2014) ncbi
Invitrogen
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1b
Invitrogen CD73 antibody (Invitrogen, 12-0739-41) was used in flow cytometry on human samples (fig 1b). Stem Cell Res Ther (2021) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:500; loading ...; fig 2e
Invitrogen CD73 antibody (eBioscience, AD2) was used in flow cytometry on human samples at 1:500 (fig 2e). Biomolecules (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:50; fig 2a
Invitrogen CD73 antibody (eBioscience/Thermo, 12-0739-42) was used in flow cytometry on human samples at 1:50 (fig 2a). Stem Cells (2019) ncbi
mouse monoclonal (7G2)
  • immunocytochemistry; human; 1:100; fig s1g
In order to describe the types, structure, components, dynamics and functionality of the tunneling nanotubes bridging neighboring human umbilical cord mesenchymal stem cells obtained from Wharton's jelly, Invitrogen CD73 antibody (Invitrogen, 410,200) was used in immunocytochemistry on human samples at 1:100 (fig s1g). Stem Cell Rev (2017) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; fig 1d
In order to explore factors that induce the transition of keratocytes to corneal mesenchymal stem cells and vice versa, Invitrogen CD73 antibody (Thermo Scientific Pierce, PA5- 11871) was used in immunocytochemistry on human samples (fig 1d). J Tissue Eng Regen Med (2018) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 3
Invitrogen CD73 antibody (eBioscience, 46-0739-42) was used in flow cytometry on human samples (fig 3). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2
Invitrogen CD73 antibody (eBioscience, 11-0739-41) was used in flow cytometry on human samples (fig 2). Stem Cell Reports (2016) ncbi
mouse monoclonal (7G2)
  • immunocytochemistry; human; 1:100; loading ...; tbl 1
In order to investigate somatic reprogramming of adult cells to induced pluripotent stem cells, Invitrogen CD73 antibody (Thermo Fisher, 41-0200) was used in immunocytochemistry on human samples at 1:100 (tbl 1). J Vis Exp (2016) ncbi
mouse monoclonal (7G2)
  • ELISA; human; 1 ug/ml; fig 5a
In order to find prognostic and predictive biomarkers for patients with colorectal cancer treated with cetuximab, Invitrogen CD73 antibody (Invitrogen, 41?\0200) was used in ELISA on human samples at 1 ug/ml (fig 5a). Cancer Med (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1b
In order to test if NR2F2 contributes to the stemness maintenance of mesenchymal stem cells, Invitrogen CD73 antibody (eBioscience, 17-0739) was used in flow cytometry on human samples (fig 1b). Stem Cells Int (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:100; fig 3
Invitrogen CD73 antibody (eBioscience, 12-0739) was used in flow cytometry on human samples at 1:100 (fig 3). BMC Musculoskelet Disord (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
Invitrogen CD73 antibody (eBioscience, 11-0739-42) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AD2)
  • immunocytochemistry; human; fig 2
Invitrogen CD73 antibody (eBioscience, AD2) was used in immunocytochemistry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
Invitrogen CD73 antibody (eBioscience, 46-0739) was used in flow cytometry on human samples . J Pediatr Surg (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CD73 antibody (eBioscience, 11-0739-42) was used in flow cytometry on human samples (fig s1b). Oncotarget (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:20
Invitrogen CD73 antibody (eBioscience, 12-0739-41) was used in flow cytometry on human samples at 1:20. Odontology (2015) ncbi
mouse monoclonal (7G2)
  • immunohistochemistry - frozen section; human; 1:100
In order to identify the mesenchymal markers on human adipose stem/progenitor cells, Invitrogen CD73 antibody (Invitrogen, 41-0200) was used in immunohistochemistry - frozen section on human samples at 1:100. Cytometry A (2013) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
In order to study the co-culture of mesenchymal stem cells with liver cells in bioartificial liver system, Invitrogen CD73 antibody (eBioscience, 17-0739-42) was used in flow cytometry on human samples . Biotechnol Bioeng (2013) ncbi
Abcam
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 2a
Abcam CD73 antibody (Abcam, ab155378) was used in flow cytometry on human samples (fig 2a). Stem Cell Res Ther (2020) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:500; loading ...; fig s2
In order to test if A2A receptor signaling governs the blood-brain barrier dynamics in sleep-restricted rats, Abcam CD73 antibody (Abcam, ab175396) was used in western blot on rat samples at 1:500 (fig s2). PLoS ONE (2016) ncbi
mouse monoclonal (7G2)
  • flow cytometry; human; 1:250; loading ...; fig 3a
  • flow cytometry; African green monkey; 1:250; loading ...; fig 3a
Abcam CD73 antibody (Abcam, ab54217) was used in flow cytometry on human samples at 1:250 (fig 3a) and in flow cytometry on African green monkey samples at 1:250 (fig 3a). Stem Cell Res Ther (2015) ncbi
domestic rabbit monoclonal (EPR6114)
  • immunohistochemistry - paraffin section; human
Abcam CD73 antibody (Epitomics, 5362-1) was used in immunohistochemistry - paraffin section on human samples . Cell Tissue Bank (2014) ncbi
mouse monoclonal (7G2)
  • blocking or activating experiments; human
  • flow cytometry; human
Abcam CD73 antibody (Abcam, ab54217) was used in blocking or activating experiments on human samples and in flow cytometry on human samples . Am J Transl Res (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • western blot; human; fig 2
Novus Biologicals CD73 antibody (Novus, NBP1-85740) was used in western blot on human samples (fig 2). Oncoimmunology (2016) ncbi
BD Biosciences
mouse monoclonal (AD2)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BD Biosciences CD73 antibody (BD Pharmingen, AD2) was used in flow cytometry on human samples at 1:100 (fig 1a). Stem Cell Res Ther (2021) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s3b
BD Biosciences CD73 antibody (BD, AD2) was used in flow cytometry on human samples (fig s3b). Front Immunol (2021) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD73 antibody (BD Biosciences, AD2) was used in flow cytometry on human samples (fig s4a). Int J Mol Sci (2021) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:5; loading ...; fig s1-3a
BD Biosciences CD73 antibody (BD Pharmingen, 561014) was used in flow cytometry on human samples at 1:5 (fig s1-3a). elife (2020) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 1f). Cell Res (2020) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 1f). Nucleic Acids Res (2020) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD73 antibody (BD Biosciences, 561258) was used in flow cytometry on human samples (fig s1a). Front Immunol (2020) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1s2, 1s3b
BD Biosciences CD73 antibody (BD, RRID:AB_2033967) was used in flow cytometry on human samples (fig 1s2, 1s3b). elife (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; rat; loading ...; fig 2b
BD Biosciences CD73 antibody (BD Pharmingen, 550257) was used in flow cytometry on rat samples (fig 2b). Connect Tissue Res (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD73 antibody (BD Pharmingen, 561014) was used in flow cytometry on human samples (fig 1b). Sci Rep (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2a
BD Biosciences CD73 antibody (BD Pharmingen, 550257) was used in flow cytometry on human samples (fig 2a). Stem Cells Int (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s2a
BD Biosciences CD73 antibody (BD, 561254) was used in flow cytometry on human samples (fig s2a). Nature (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences CD73 antibody (BD Biosciences, AD2) was used in flow cytometry on human samples (fig 2d). J Immunol (2019) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 5a
In order to detail MAIT cell responses to various microorganisms and cytokines, BD Biosciences CD73 antibody (BD Biosciences, AD2) was used in flow cytometry on human samples (fig 5a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2b
BD Biosciences CD73 antibody (BD PharmingenTM, 550257) was used in flow cytometry on human samples (fig 2b). Cell J (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s4c
BD Biosciences CD73 antibody (BD Pharmingen, 560847) was used in flow cytometry on human samples (fig s4c). Hum Mol Genet (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:50; loading ...; tbl 1
BD Biosciences CD73 antibody (Becton, 550257) was used in flow cytometry on human samples at 1:50 (tbl 1). Sci Rep (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s1a
BD Biosciences CD73 antibody (BD, AD2) was used in flow cytometry on human samples (fig s1a). Int J Mol Sci (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1b
In order to evaluate the myogenic potential and proliferative capacity of human alveolar mucosa cells, BD Biosciences CD73 antibody (BD Pharmingen, 550257) was used in flow cytometry on human samples (fig 1b). Cell Cycle (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig s1a
In order to assess the human hematopoietic stem cell self-renewal potential and quiescence in an in vitro leukemic niche without leukemic cells, BD Biosciences CD73 antibody (BD Pharmingen, AD2) was used in flow cytometry on human samples (fig s1a). Exp Hematol Oncol (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2c
In order to propose that decidual stromal cells are a cellular source of BAFF for B cells present in decidua during pregnancy, BD Biosciences CD73 antibody (BD Bioscience, 550257) was used in flow cytometry on human samples (fig 2c). Sci Rep (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; mouse; loading ...; fig 2
In order to assess the effect of adult Sertoli cell condition medium on the induction of germ cells from bone marrow mesenchymal stem cells, BD Biosciences CD73 antibody (BD Bioscience, 550257) was used in flow cytometry on mouse samples (fig 2). Iran J Basic Med Sci (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; domestic sheep; loading ...
In order to discuss methods to generate ovine mesenchymal stromal cells, BD Biosciences CD73 antibody (BDPharmingen, AD2) was used in flow cytometry on domestic sheep samples . J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 6c
In order to measure cell size and cell surface markers of human MSCs after intravenous injection in immune competent mice, BD Biosciences CD73 antibody (Becton, Dickinson, and Company, AD2) was used in flow cytometry on human samples (fig 6c). Cytotherapy (2017) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s1
BD Biosciences CD73 antibody (BD Pharmingen, 550257) was used in flow cytometry on human samples (fig s1). Sci Rep (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 5
BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples (fig 5). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (AD2)
  • ELISA; human; 3.3 ug/ml; fig 5a
In order to find prognostic and predictive biomarkers for patients with colorectal cancer treated with cetuximab, BD Biosciences CD73 antibody (BD Biosciences, 550256) was used in ELISA on human samples at 3.3 ug/ml (fig 5a). Cancer Med (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2
BD Biosciences CD73 antibody (BD Pharmingen, AD2) was used in flow cytometry on human samples (fig 2). Cytotherapy (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:50; fig 1e
BD Biosciences CD73 antibody (BD Biosciences, 561014) was used in flow cytometry on human samples at 1:50 (fig 1e). Mol Med Rep (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s2
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig s2). Stem Cell Reports (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; domestic sheep; 1:10; fig 3
In order to define a set of monoclonal antibodies for the immunophenotypic characterization of ovine mesenchymal stem cells, BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on domestic sheep samples at 1:10 (fig 3). Cytometry A (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
BD Biosciences CD73 antibody (BD pharmingen, 550257) was used in flow cytometry on human samples (fig 1). Stem Cells Int (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...
BD Biosciences CD73 antibody (BD, AD2) was used in flow cytometry on human samples . BMC Musculoskelet Disord (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, BD Biosciences CD73 antibody (BD Pharmingen, BD550257) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 1). Cell Res (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; tbl 2
In order to study human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue, BD Biosciences CD73 antibody (BD Pharmingen, 550257) was used in flow cytometry on human samples (tbl 2). Int J Mol Med (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 3
BD Biosciences CD73 antibody (BD Pharmingen, 561254) was used in flow cytometry on human samples (fig 3). BMC Res Notes (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:100; fig 2g
In order to study the differentiation of oral mucosa stromal cells into neural crest stem cells and assess their therapeutic value, BD Biosciences CD73 antibody (BD Pharmingen, AD2) was used in flow cytometry on human samples at 1:100 (fig 2g). Stem Cells Transl Med (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:200; fig 1d
BD Biosciences CD73 antibody (BD Pharmingen, 562817) was used in flow cytometry on human samples at 1:200 (fig 1d). Eur J Immunol (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; tbl 1
In order to determine support for heparin-free mesenchymal stem cell propagation in human platelet lysate by mechanical fibrinogen-depletion, BD Biosciences CD73 antibody (Becton Dickinson, AD2) was used in flow cytometry on human samples (tbl 1). J Transl Med (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD73 antibody (BD Biosciences, AD2) was used in flow cytometry on human samples (fig 1c). Cytotherapy (2016) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BD Biosciences CD73 antibody (BD Pharmingen, 561254) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; cat; 1:25; tbl 3
BD Biosciences CD73 antibody (BD Biosciences, 550256) was used in flow cytometry on cat samples at 1:25 (tbl 3). Cell Reprogram (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; tbl 1
BD Biosciences CD73 antibody (BD bioscience, 550257) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2
BD Biosciences CD73 antibody (BD Biosciences, 561014) was used in flow cytometry on human samples (fig 2). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:20; fig s5
In order to optimize conditions to promote the proliferation of multipotent cardiovascular progenitor cells, BD Biosciences CD73 antibody (BD, . 550257) was used in flow cytometry on human samples at 1:20 (fig s5). Nat Biotechnol (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2
BD Biosciences CD73 antibody (BD Biosciences, 561258) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:100; fig 2
BD Biosciences CD73 antibody (BD Bioscience, 560847) was used in flow cytometry on human samples at 1:100 (fig 2). Stem Cells Int (2015) ncbi
mouse monoclonal (AD2)
  • immunocytochemistry; human; fig s1
BD Biosciences CD73 antibody (BD, 550257) was used in immunocytochemistry on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 4
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 4). PLoS ONE (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig s4
BD Biosciences CD73 antibody (BD Pharmingen, 550256) was used in flow cytometry on human samples (fig s4). Stem Cell Reports (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 2
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
In order to discuss the contribution of missense mutations in PDE3A to hypertension, BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples . Nat Genet (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples . Bone (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; domestic horse; fig 4
BD Biosciences CD73 antibody (BD Biosciences, 550256) was used in flow cytometry on domestic horse samples (fig 4). J Orthop Res (2015) ncbi
mouse monoclonal (AD2)
  • immunocytochemistry; human
In order to generate patient-derived iPSCs from a Li-Fraumeni syndrome family and assess the role of mutant p53 in the development of osteosarcoma, BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in immunocytochemistry on human samples . Cell (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 5:200
In order to study the differences between human and mouse ATOH1 in Wharton's jelly cells, BD Biosciences CD73 antibody (BD Biosciences, 561254) was used in flow cytometry on human samples at 5:200. Tissue Eng Part A (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 5
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples (fig 5). Stem Cell Reports (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
In order to show that intermediate DNA methylation is a conserved signature of gene regulation and exon usage, BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples . Nat Commun (2015) ncbi
mouse monoclonal (AD2)
  • immunocytochemistry; human
In order to report a protocol using a non-integrating Sendai virus vector for transduction of Yamanaka factors into urine cells collected from patients with muscular dystrophy, BD Biosciences CD73 antibody (BD Biosciences, 561014) was used in immunocytochemistry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (B.D. Biosciences, 561014) was used in flow cytometry on human samples . World J Stem Cells (2015) ncbi
mouse monoclonal (AD2)
  • immunohistochemistry - paraffin section; rat; fig  6
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in immunohistochemistry - paraffin section on rat samples (fig  6). J Control Release (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 5
BD Biosciences CD73 antibody (BD Bioscience, AD2) was used in flow cytometry on human samples (fig 5). Stem Cells Dev (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD Biosciences, 561254) was used in flow cytometry on human samples . Tissue Eng Part A (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
In order to study the effect of mesenchymal stem cells on the anti-bacterial activity of neutrophil granulocytes, BD Biosciences CD73 antibody (BD Bioscience, AD2) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples . F1000Res (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:500
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:100
In order to evaluate the osteogenic capacity of bone marrow mesenchymal stream cells and gingiva-derived mesenchymal stromal cells, BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples at 1:100. Biomed Mater (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BDBiosciences, 550257) was used in flow cytometry on human samples . Stem Cells Dev (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; loading ...; fig 1a
In order to isolate and characterize mesenchymal stromal cells from head and neck squamous cell carcinoma and study their interaction with tumor cells, BD Biosciences CD73 antibody (BD Bioscience, AD2) was used in flow cytometry on human samples (fig 1a). Stem Cell Res Ther (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; 1:50; fig 6
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples at 1:50 (fig 6). Nat Commun (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples . Cell Tissue Res (2014) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
BD Biosciences CD73 antibody (BD, AD2) was used in flow cytometry on human samples (fig 1). J Tissue Eng Regen Med (2015) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD Biosciences, AD2) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
BD Biosciences CD73 antibody (BD Biosciences, 550257) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human
In order to identify the mesenchymal markers on human adipose stem/progenitor cells, BD Biosciences CD73 antibody (BD, 550257) was used in flow cytometry on human samples . Cytometry A (2013) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 3
BD Biosciences CD73 antibody (BD Biosciences, 560847) was used in flow cytometry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (AD2)
  • flow cytometry; human; fig 1
BD Biosciences CD73 antibody (BD Pharmingen, 550257) was used in flow cytometry on human samples (fig 1). Stem Cells Dev (2010) ncbi
Articles Reviewed
  1. Dong N, Zhou P, Li D, Zhu H, Liu L, Ma H, et al. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK/STAT pathways. World J Stem Cells. 2022;14:556-576 pubmed publisher
  2. Ye Y, Zhang X, Su D, Ren Y, Cheng F, Yao Y, et al. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling. Stem Cell Res Ther. 2022;13:465 pubmed publisher
  3. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  4. Elhussieny A, Nogami K, Sakai Takemura F, Maruyama Y, Takemura N, Soliman W, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR). Stem Cell Res Ther. 2021;12:532 pubmed publisher
  5. Li Y, Shi G, Han Y, Shang H, Li H, Liang W, et al. Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model. Stem Cell Res Ther. 2021;12:407 pubmed publisher
  6. Marozin S, Simon Nobbe B, Irausek S, Chung L, Lepperdinger G. Kinship of conditionally immortalized cells derived from fetal bone to human bone-derived mesenchymal stroma cells. Sci Rep. 2021;11:10933 pubmed publisher
  7. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  8. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed publisher
  9. Zhang Q, Xiang E, Rao W, Zhang Y, Xiao C, Li C, et al. Intra-articular injection of human umbilical cord mesenchymal stem cells ameliorates monosodium iodoacetate-induced osteoarthritis in rats by inhibiting cartilage degradation and inflammation. Bone Joint Res. 2021;10:226-236 pubmed publisher
  10. Sünderhauf A, Hicken M, Schlichting H, Skibbe K, Ragab M, Raschdorf A, et al. Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis. Cell Mol Gastroenterol Hepatol. 2021;12:229-250 pubmed publisher
  11. Jakob M, Hambrecht M, Spiegel J, Kitz J, Canis M, Dressel R, et al. Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Show Comparable Functionality to Their Autologous Origin. Cells. 2020;10: pubmed publisher
  12. Xu J, Wang Y, Hsu C, Negri S, Tower R, Gao Y, et al. Lysosomal protein surface expression discriminates fat- from bone-forming human mesenchymal precursor cells. elife. 2020;9: pubmed publisher
  13. Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30:794-809 pubmed publisher
  14. Hu H, Ji Q, Song M, Ren J, Liu Z, Wang Z, et al. ZKSCAN3 counteracts cellular senescence by stabilizing heterochromatin. Nucleic Acids Res. 2020;48:6001-6018 pubmed publisher
  15. Burand A, Di L, Boland L, Boyt D, Schrodt M, Santillan D, et al. Aggregation of Human Mesenchymal Stromal Cells Eliminates Their Ability to Suppress Human T Cells. Front Immunol. 2020;11:143 pubmed publisher
  16. Beltran Camacho L, Jimenez Palomares M, Rojas Torres M, Sánchez Gomar I, Rosal Vela A, Eslava Alcon S, et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res Ther. 2020;11:106 pubmed publisher
  17. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed publisher
  18. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  19. Shao Q, Esseltine J, Huang T, Novielli Kuntz N, Ching J, SAMPSON J, et al. Connexin43 is Dispensable for Early Stage Human Mesenchymal Stem Cell Adipogenic Differentiation But is Protective against Cell Senescence. Biomolecules. 2019;9: pubmed publisher
  20. Xu J, Wang Y, Hsu C, Gao Y, Meyers C, Chang L, et al. Human perivascular stem cell-derived extracellular vesicles mediate bone repair. elife. 2019;8: pubmed publisher
  21. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  22. Nan L, Wang F, Ran D, Zhou S, Liu Y, Zhang Z, et al. Naringin alleviates H2O2-induced apoptosis via the PI3K/Akt pathway in rat nucleus pulposus-derived mesenchymal stem cells. Connect Tissue Res. 2019;:1-14 pubmed publisher
  23. Shokri M, Bozorgmehr M, Ghanavatinejad A, Falak R, Aleahmad M, Kazemnejad S, et al. Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells. Sci Rep. 2019;9:10007 pubmed publisher
  24. Guiu J, Hannezo E, Yui S, Demharter S, Ulyanchenko S, Maimets M, et al. Tracing the origin of adult intestinal stem cells. Nature. 2019;570:107-111 pubmed publisher
  25. Dmitrieva R, Lelyavina T, Komarova M, Galenko V, Ivanova O, Tikanova P, et al. Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations. Stem Cells Int. 2019;2019:5690345 pubmed publisher
  26. Wimmer R, Leopoldi A, Aichinger M, Wick N, Hantusch B, Novatchkova M, et al. Human blood vessel organoids as a model of diabetic vasculopathy. Nature. 2019;565:505-510 pubmed publisher
  27. Choi Y, Park S, Sun Y, Yoo J, Pudupakam R, Foo S, et al. Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis. Nat Microbiol. 2019;4:429-437 pubmed publisher
  28. Kumar A, Lee J, Suknuntha K, D Souza S, Thakur A, Slukvin I. NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells. J Immunol. 2019;202:770-776 pubmed publisher
  29. Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, et al. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease. Mol Psychiatry. 2018;: pubmed publisher
  30. Klein M, Dickson M, Antonescu C, Qin L, Dooley S, Barlas A, et al. PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence. Oncogene. 2018;37:5066-5078 pubmed publisher
  31. Li T, Song L, Sun Y, Li J, Yi C, Lam S, et al. Tip60-mediated lipin 1 acetylation and ER translocation determine triacylglycerol synthesis rate. Nat Commun. 2018;9:1916 pubmed publisher
  32. Abboud M, Rybchyn M, Ning Y, Brennan Speranza T, Girgis C, Gunton J, et al. 1,25-Dihydroxycholecalciferol (calcitriol) modifies uptake and release of 25-hydroxycholecalciferol in skeletal muscle cells in culture. J Steroid Biochem Mol Biol. 2018;177:109-115 pubmed publisher
  33. Yang Y, Yang S, Guo J, Cui Y, Tang B, Li X, et al. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17. J Neurosci. 2017;37:9101-9115 pubmed publisher
  34. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed publisher
  35. Wassermann Dozorets R, Rubinstein M. C/EBPβ LIP augments cell death by inducing osteoglycin. Cell Death Dis. 2017;8:e2733 pubmed publisher
  36. Emadedin M, Labibzadeh N, Fazeli R, Mohseni F, Hosseini S, Moghadasali R, et al. Percutaneous Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Implantation Is Safe for Reconstruction of Human Lower Limb Long Bone Atrophic Nonunion. Cell J. 2017;19:159-165 pubmed
  37. Miller E, Kobayashi G, Musso C, Allen M, Ishiy F, de Caires L, et al. EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome. Hum Mol Genet. 2017;26:2177-2191 pubmed publisher
  38. Di Maggio N, Martella E, Frismantiene A, Resink T, Schreiner S, Lucarelli E, et al. Extracellular matrix and α5β1 integrin signaling control the maintenance of bone formation capacity by human adipose-derived stromal cells. Sci Rep. 2017;7:44398 pubmed publisher
  39. Vernot J, Bonilla X, Rodriguez Pardo V, Vanegas N. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment. Int J Mol Sci. 2017;18: pubmed publisher
  40. Sanchez V, Villalba N, Fiore L, Luzzani C, Miriuka S, Boveris A, et al. Characterization of Tunneling Nanotubes in Wharton's jelly Mesenchymal Stem Cells. An Intercellular Exchange of Components between Neighboring Cells. Stem Cell Rev. 2017;13:491-498 pubmed publisher
  41. Yang G, Zhao Z, Qin T, Wang D, Chen L, Xiang R, et al. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation. FASEB J. 2017;31:2001-2012 pubmed publisher
  42. Zorin V, Pulin A, Eremin I, Korsakov I, Zorina A, Khromova N, et al. Myogenic potential of human alveolar mucosa derived cells. Cell Cycle. 2017;16:545-555 pubmed publisher
  43. Vanegas N, Vernot J. Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche. Exp Hematol Oncol. 2017;6:2 pubmed publisher
  44. Lundell A, Nordström I, Andersson K, Lundqvist C, Telemo E, Nava S, et al. IFN type I and II induce BAFF secretion from human decidual stromal cells. Sci Rep. 2017;7:39904 pubmed publisher
  45. Steffen J, Vashisht A, Wan J, Jen J, Claypool S, Wohlschlegel J, et al. Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria. Mol Biol Cell. 2017;28:600-612 pubmed publisher
  46. Monfared M, Minaee B, Rastegar T, Khrazinejad E, Barbarestani M. Sertoli cell condition medium can induce germ like cells from bone marrow derived mesenchymal stem cells. Iran J Basic Med Sci. 2016;19:1186-1192 pubmed
  47. Andresen V, Erikstein B, Mukherjee H, Sulen A, Popa M, S rnes S, et al. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis. 2016;7:e2497 pubmed publisher
  48. Wei C, Mei J, Tang L, Liu Y, Li D, Li M, et al. 1-Methyl-tryptophan attenuates regulatory T cells differentiation due to the inhibition of estrogen-IDO1-MRC2 axis in endometriosis. Cell Death Dis. 2016;7:e2489 pubmed publisher
  49. Hurtado Alvarado G, Dominguez Salazar E, Velazquez Moctezuma J, Gómez González B. A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction. PLoS ONE. 2016;11:e0167236 pubmed publisher
  50. Bendre S, Rondelet A, Hall C, Schmidt N, Lin Y, Brouhard G, et al. GTSE1 tunes microtubule stability for chromosome alignment and segregation by inhibiting the microtubule depolymerase MCAK. J Cell Biol. 2016;215:631-647 pubmed
  51. Sulek J, Robinson S, Petrossian A, Zhou S, Goliadze E, Manjili M, et al. Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model. Prostate. 2017;77:361-373 pubmed publisher
  52. Caminal M, Velez R, Rabanal R, Vivas D, Batlle Morera L, Aguirre M, et al. A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies. J Tissue Eng Regen Med. 2017;11:3408-3416 pubmed publisher
  53. Leibacher J, Dauber K, Ehser S, Brixner V, Kollar K, Vogel A, et al. Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. Cytotherapy. 2017;19:61-74 pubmed publisher
  54. Yu L, Li J, Xu S, Navia Miranda M, Wang G, Duan Y. An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report. Diagn Pathol. 2016;11:98 pubmed
  55. Sidney L, Hopkinson A. Corneal keratocyte transition to mesenchymal stem cell phenotype and reversal using serum-free medium supplemented with fibroblast growth factor-2, transforming growth factor-β3 and retinoic acid. J Tissue Eng Regen Med. 2018;12:e203-e215 pubmed publisher
  56. Haney S, Upchurch G, Opavska J, Klinkebiel D, Appiah A, Smith L, et al. Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. Sci Rep. 2016;6:34222 pubmed publisher
  57. Maroui M, Callé A, Cohen C, Streichenberger N, Texier P, Takissian J, et al. Latency Entry of Herpes Simplex Virus 1 Is Determined by the Interaction of Its Genome with the Nuclear Environment. PLoS Pathog. 2016;12:e1005834 pubmed publisher
  58. Tyurin Kuzmin P, Fadeeva J, Kanareikina M, Kalinina N, Sysoeva V, Dyikanov D, et al. Activation of ?-adrenergic receptors is required for elevated ?1A-adrenoreceptors expression and signaling in mesenchymal stromal cells. Sci Rep. 2016;6:32835 pubmed publisher
  59. Wu Y, Xie R, Liu X, Wang J, Peng Y, Tang W, et al. Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer. Oncol Rep. 2016;36:2151-9 pubmed publisher
  60. Yamaguchi J, Mino Kenudson M, Liss A, Chowdhury S, Wang T, Fernández Del Castillo C, et al. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice. Gastroenterology. 2016;151:1232-1244.e10 pubmed publisher
  61. Camilleri E, Gustafson M, Dudakovic A, Riester S, Garces C, Paradise C, et al. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production. Stem Cell Res Ther. 2016;7:107 pubmed publisher
  62. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed publisher
  63. Quintanilla R, Asprer J, Sylakowski K, Lakshmipathy U. Kinetic Measurement and Real Time Visualization of Somatic Reprogramming. J Vis Exp. 2016;: pubmed publisher
  64. Hatch A, Sibley A, Starr M, Brady J, Jiang C, Jia J, et al. Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Cancer Med. 2016;5:2249-60 pubmed publisher
  65. Codinach M, Blanco M, Ortega I, Lloret M, Reales L, Coca M, et al. Design and validation of a consistent and reproducible manufacture process for the production of clinical-grade bone marrow-derived multipotent mesenchymal stromal cells. Cytotherapy. 2016;18:1197-208 pubmed publisher
  66. Ren Z, Yuan Y, Ji T, Zhang C. CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma. Oncol Lett. 2016;12:556-562 pubmed
  67. Chen X, Kong X, Liu D, Gao P, Zhang Y, Li P, et al. In vitro differentiation of endometrial regenerative cells into smooth muscle cells: ? potential approach for the management of pelvic organ prolapse. Int J Mol Med. 2016;38:95-104 pubmed publisher
  68. Gómez SanMiguel A, Villanúa M, Martín A, López Calderón A. D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway. PLoS ONE. 2016;11:e0155645 pubmed publisher
  69. Zhang N, Chen B, Wang W, Chen C, Kang J, Deng S, et al. Isolation, characterization and multi-lineage differentiation of stem cells from human exfoliated deciduous teeth. Mol Med Rep. 2016;14:95-102 pubmed publisher
  70. Saxena S, Ronn R, Guibentif C, Moraghebi R, Woods N. Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation. Stem Cell Reports. 2016;6:692-703 pubmed publisher
  71. Khan M, Chandrashekran A, Smith R, Dudhia J. Immunophenotypic characterization of ovine mesenchymal stem cells. Cytometry A. 2016;89:443-50 pubmed publisher
  72. El Kehdy H, Pourcher G, Zhang W, Hamidouche Z, Goulinet Mainot S, Sokal E, et al. Hepatocytic Differentiation Potential of Human Fetal Liver Mesenchymal Stem Cells: In Vitro and In Vivo Evaluation. Stem Cells Int. 2016;2016:6323486 pubmed publisher
  73. Zou L, Chen Q, Quanbeck Z, Bechtold J, Kaufman D. Angiogenic activity mediates bone repair from human pluripotent stem cell-derived osteogenic cells. Sci Rep. 2016;6:22868 pubmed publisher
  74. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  75. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  76. Pilge H, Fröbel J, Mrotzek S, Fischer J, Prodinger P, Zilkens C, et al. Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban. BMC Musculoskelet Disord. 2016;17:108 pubmed publisher
  77. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  78. Muntión S, Ramos T, Diez Campelo M, Rosón B, Sánchez Abarca L, Misiewicz Krzeminska I, et al. Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients. PLoS ONE. 2016;11:e0146722 pubmed publisher
  79. Huang H, Wang S, Gui J, Shen H. A study to identify and characterize the stem/progenitor cell in rabbit meniscus. Cytotechnology. 2016;68:2083-103 pubmed publisher
  80. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  81. Zhu N, Wang H, Wang B, Wei J, Shan W, Feng J, et al. A Member of the Nuclear Receptor Superfamily, Designated as NR2F2, Supports the Self-Renewal Capacity and Pluripotency of Human Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Int. 2016;2016:5687589 pubmed publisher
  82. Pan H, Guan D, Liu X, Li J, Wang L, Wu J, et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res. 2016;26:190-205 pubmed publisher
  83. Heo J, Choi Y, Kim H, Kim H. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37:115-25 pubmed publisher
  84. Schosserer M, Reynoso R, Wally V, Jug B, Kantner V, Weilner S, et al. Urine is a novel source of autologous mesenchymal stem cells for patients with epidermolysis bullosa. BMC Res Notes. 2015;8:767 pubmed publisher
  85. Abe S, Yamaguchi S, Sato Y, Harada K. Sphere-Derived Multipotent Progenitor Cells Obtained From Human Oral Mucosa Are Enriched in Neural Crest Cells. Stem Cells Transl Med. 2016;5:117-28 pubmed publisher
  86. Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S. Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2016;46:440-5 pubmed publisher
  87. Laner Plamberger S, Lener T, Schmid D, Streif D, Salzer T, Öller M, et al. Mechanical fibrinogen-depletion supports heparin-free mesenchymal stem cell propagation in human platelet lysate. J Transl Med. 2015;13:354 pubmed publisher
  88. Oliver Vila I, Coca M, Grau Vorster M, Pujals Fonts N, Caminal M, Casamayor Genescà A, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. Cytotherapy. 2016;18:25-35 pubmed publisher
  89. Bai H, Liu Y, Xie Y, Hoyle D, Brodsky R, Cheng L, et al. Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells. J Cell Physiol. 2016;231:1065-76 pubmed publisher
  90. Beckmann R, Lippross S, Hartz C, Tohidnezhad M, Ferreira M, Neuss Stein S, et al. Abrasion arthroplasty increases mesenchymal stem cell content of postoperative joint effusions. BMC Musculoskelet Disord. 2015;16:250 pubmed publisher
  91. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  92. Gómez M, Qin Q, Biancardi M, Galiguis J, Dumas C, MacLean R, et al. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue. Cell Reprogram. 2015;17:376-92 pubmed publisher
  93. Pogozhykh O, Pogozhykh D, Neehus A, Hoffmann A, Blasczyk R, Müller T. Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term culture. Stem Cell Res Ther. 2015;6:150 pubmed publisher
  94. Monteiro Carvalho Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N, et al. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS ONE. 2015;10:e0136145 pubmed publisher
  95. Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144 pubmed publisher
  96. Birket M, Ribeiro M, Verkerk A, Ward D, Leitoguinho A, Den Hartogh S, et al. Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells. Nat Biotechnol. 2015;33:970-9 pubmed publisher
  97. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed publisher
  98. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed publisher
  99. Croes M, Oner F, Kruyt M, Blokhuis T, Bastian O, Dhert W, et al. Proinflammatory Mediators Enhance the Osteogenesis of Human Mesenchymal Stem Cells after Lineage Commitment. PLoS ONE. 2015;10:e0132781 pubmed publisher
  100. Southwell A, Smith S, Davis T, Caron N, Villanueva E, Xie Y, et al. Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Sci Rep. 2015;5:12166 pubmed publisher
  101. Wu Y, Feng G, Song J, Zhang Y, Yu Y, Huang L, et al. TrAmplification of Human Dental Follicle Cells by piggyBac Transposon - Mediated Reversible Immortalization System. PLoS ONE. 2015;10:e0130937 pubmed publisher
  102. James S, Fox J, Afsari F, Lee J, Clough S, Knight C, et al. Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. Stem Cell Reports. 2015;4:1004-15 pubmed publisher
  103. Takeuchi M, Higashino A, Takeuchi K, Hori Y, Koshiba Takeuchi K, Makino H, et al. Transcriptional Dynamics of Immortalized Human Mesenchymal Stem Cells during Transformation. PLoS ONE. 2015;10:e0126562 pubmed publisher
  104. Higuchi A, Wang C, Ling Q, Lee H, Kumar S, Chang Y, et al. A hybrid-membrane migration method to isolate high-purity adipose-derived stem cells from fat tissues. Sci Rep. 2015;5:10217 pubmed publisher
  105. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed publisher
  106. Zhou F, Gao S, Wang L, Sun C, Chen L, Yuan P, et al. Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model. Stem Cell Res Ther. 2015;6:92 pubmed publisher
  107. Lee J, Park J, Kim T, Jung B, Lee Y, Shim E, et al. Human bone marrow stem cells cultured under hypoxic conditions present altered characteristics and enhanced in vivo tissue regeneration. Bone. 2015;78:34-45 pubmed publisher
  108. Williamson K, Lee K, Humphreys W, Comerford E, Clegg P, Canty Laird E. Restricted differentiation potential of progenitor cell populations obtained from the equine superficial digital flexor tendon (SDFT). J Orthop Res. 2015;33:849-58 pubmed publisher
  109. Lee D, Su J, Kim H, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240-54 pubmed publisher
  110. Ali H, Al Yatama M, Abu Farha M, Behbehani K, Al Madhoun A. Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS ONE. 2015;10:e0122465 pubmed publisher
  111. Kumari A, Owen N, Juarez E, McCullough A. BLM protein mitigates formaldehyde-induced genomic instability. DNA Repair (Amst). 2015;28:73-82 pubmed publisher
  112. Mellott A, Devarajan K, Shinogle H, Moore D, Talata Z, Laurence J, et al. Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues. Tissue Eng Part A. 2015;21:1795-809 pubmed publisher
  113. Narcisi R, Cleary M, Brama P, Hoogduijn M, Tüysüz N, ten Berge D, et al. Long-term expansion, enhanced chondrogenic potential, and suppression of endochondral ossification of adult human MSCs via WNT signaling modulation. Stem Cell Reports. 2015;4:459-72 pubmed publisher
  114. Woo J, Zhao X, Khan H, Penn C, Wang X, Joly Amado A, et al. Slingshot-Cofilin activation mediates mitochondrial and synaptic dysfunction via Aβ ligation to β1-integrin conformers. Cell Death Differ. 2015;22:921-34 pubmed publisher
  115. Elliott G, Hong C, Xing X, Zhou X, Li D, Coarfa C, et al. Intermediate DNA methylation is a conserved signature of genome regulation. Nat Commun. 2015;6:6363 pubmed publisher
  116. Afzal M, Strande J. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp. 2015;:52032 pubmed publisher
  117. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  118. Lankford L, Selby T, Becker J, Ryzhuk V, Long C, Farmer D, et al. Early gestation chorionic villi-derived stromal cells for fetal tissue engineering. World J Stem Cells. 2015;7:195-207 pubmed publisher
  119. Lee Y, Lim K, Oh J, Yoon A, Joo W, Kim H, et al. Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs). J Control Release. 2015;205:128-33 pubmed publisher
  120. Yang Y, Otte A, Hass R. Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines. Stem Cells Dev. 2015;24:1205-22 pubmed publisher
  121. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed publisher
  122. Johnstone S, Liley M, Dalby M, Barnett S. Comparison of human olfactory and skeletal MSCs using osteogenic nanotopography to demonstrate bone-specific bioactivity of the surfaces. Acta Biomater. 2015;13:266-76 pubmed publisher
  123. Wang C, Zhang W, Fu M, Yang A, Huang H, Xie J. Establishment of human pancreatic cancer gemcitabine‑resistant cell line with ribonucleotide reductase overexpression. Oncol Rep. 2015;33:383-90 pubmed publisher
  124. Guerrero J, Oliveira H, Catros S, Siadous R, Derkaoui S, Bareille R, et al. The use of total human bone marrow fraction in a direct three-dimensional expansion approach for bone tissue engineering applications: focus on angiogenesis and osteogenesis. Tissue Eng Part A. 2015;21:861-74 pubmed publisher
  125. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, et al. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014;9:e106903 pubmed publisher
  126. Kouroupis D, Churchman S, McGonagle D, Jones E. The assessment of CD146-based cell sorting and telomere length analysis for establishing the identity of mesenchymal stem cells in human umbilical cord. F1000Res. 2014;3:126 pubmed publisher
  127. Tsai H, Deng W, Lai W, Chiu W, Yang C, Tsai Y, et al. Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. PLoS ONE. 2014;9:e104937 pubmed publisher
  128. Zorin V, Komlev V, Zorina A, Khromova N, Solovieva E, Fedotov A, et al. Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts. Biomed Mater. 2014;9:055005 pubmed publisher
  129. Park D, Park J, Lee J, Kim T, Kim K, Jung B, et al. Effect of FGF-2 on collagen tissue regeneration by human vertebral bone marrow stem cells. Stem Cells Dev. 2015;24:228-43 pubmed publisher
  130. Kansy B, Dißmann P, Hemeda H, Bruderek K, Westerkamp A, Jagalski V, et al. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res Ther. 2014;5:95 pubmed publisher
  131. Liu G, Suzuki K, Li M, Qu J, Montserrat N, Tarantino C, et al. Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs. Nat Commun. 2014;5:4330 pubmed publisher
  132. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  133. Schuler P, Saze Z, Hong C, Muller L, Gillespie D, Cheng D, et al. Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clin Exp Immunol. 2014;177:531-43 pubmed publisher
  134. Pei M, Li J, Zhang Y, Liu G, Wei L, Zhang Y. Expansion on a matrix deposited by nonchondrogenic urine stem cells strengthens the chondrogenic capacity of repeated-passage bone marrow stromal cells. Cell Tissue Res. 2014;356:391-403 pubmed publisher
  135. Laurent R, Nallet A, Obert L, Nicod L, Gindraux F. Storage and qualification of viable intact human amniotic graft and technology transfer to a tissue bank. Cell Tissue Bank. 2014;15:267-75 pubmed publisher
  136. Häusler S, Del Barrio I, Diessner J, Stein R, Strohschein J, Honig A, et al. Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res. 2014;6:129-39 pubmed
  137. Aomatsu E, Takahashi N, Sawada S, Okubo N, Hasegawa T, Taira M, et al. Novel SCRG1/BST1 axis regulates self-renewal, migration, and osteogenic differentiation potential in mesenchymal stem cells. Sci Rep. 2014;4:3652 pubmed publisher
  138. Torii D, Konishi K, Watanabe N, Goto S, Tsutsui T. Cementogenic potential of multipotential mesenchymal stem cells purified from the human periodontal ligament. Odontology. 2015;103:27-35 pubmed publisher
  139. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher
  140. Chicoine L, Rodino Klapac L, Shao G, Xu R, Bremer W, Camboni M, et al. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin ?2 surrogates. Mol Ther. 2014;22:713-24 pubmed publisher
  141. Denecke B, Horsch L, Radtke S, Fischer J, Horn P, Giebel B. Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering. J Tissue Eng Regen Med. 2015;9:E84-97 pubmed publisher
  142. Roubelakis M, Tsaknakis G, Pappa K, Anagnou N, Watt S. Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS ONE. 2013;8:e54747 pubmed publisher
  143. Raynaud C, Halabi N, Elliott D, Pasquier J, Elefanty A, Stanley E, et al. Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS ONE. 2013;8:e54524 pubmed publisher
  144. Zimmerlin L, Donnenberg V, Rubin J, Donnenberg A. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A. 2013;83:134-40 pubmed publisher
  145. Yang Y, Li J, Pan X, Zhou P, Yu X, Cao H, et al. Co-culture with mesenchymal stem cells enhances metabolic functions of liver cells in bioartificial liver system. Biotechnol Bioeng. 2013;110:958-68 pubmed publisher
  146. Kim S, Moon G, Cho Y, Kang H, Hyung N, Kim D, et al. Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease. PLoS ONE. 2012;7:e37036 pubmed publisher
  147. Hsieh J, Fu Y, Chang S, Tsuang Y, Wang H. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev. 2010;19:1895-910 pubmed publisher